Date Name Title Filing Type Shares Traded Price Range Total Held
Jul 18, 2018 EVP and CFO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 6,988 -- 23,181
Jul 18, 2018 EVP and CFO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 22,260 -- 22,260
Jul 18, 2018 EVP and CFO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 13,975 -- 13,975
Jul 18, 2018 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 6,307 -- 58,962
Jul 18, 2018 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 6,307 -- 48,484
Jul 18, 2018 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 6,307 -- 80,978
Jul 18, 2018 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 6,307 -- 14,599
Jul 18, 2018 SVP/GM, Global Vascular Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 4,748 -- 17,431
Jul 18, 2018 SVP/GM, Global Vascular Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,126 -- 15,126
Jul 18, 2018 SVP/GM, Global Vascular Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 9,496 -- 9,496
 For recent transactions, including derivative transactions, see our Section 16 SEC filings page.